Bioventix PLC (AIM:BVXP)
United Kingdom · Delayed Price · Currency is GBP · Price in GBX 2,025.00
-25.00 (-1.22%)
Nov 4, 2026, 4:54 PM GMT
Bioventix Income Statement
Financials in millions GBP. Fiscal year is July - June.
Millions GBP. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 12.97 | 13.12 | 13.61 | 12.82 | 11.72 | |
Revenue Growth | -1.10% | -3.61% | 6.17% | 9.36% | 7.22% |
Cost of Revenue | 1.11 | 1.2 | 0.93 | 0.83 | 0.71 |
Gross Profit | 11.86 | 11.92 | 12.68 | 11.99 | 11.01 |
Selling, General & Admin | 2.04 | 2.05 | 1.99 | 1.77 | 1.61 |
Research & Development | -0.29 | -0.3 | -0.03 | -0.03 | -0.02 |
Operating Expenses | 1.84 | 1.84 | 2.05 | 1.92 | 1.83 |
Operating Income | 10.03 | 10.07 | 10.63 | 10.07 | 9.18 |
Interest Expense | -0 | - | - | - | -0 |
Interest & Investment Income | 0.14 | 0.19 | 0.2 | 0.1 | 0 |
Currency Exchange Gain (Loss) | 0.06 | -0.17 | -0.04 | -0.04 | 0.09 |
EBT Excluding Unusual Items | 10.23 | 10.1 | 10.79 | 10.13 | 9.28 |
Gain (Loss) on Sale of Investments | - | - | -0.18 | - | - |
Pretax Income | 10.23 | 10.1 | 10.6 | 10.13 | 9.28 |
Income Tax Expense | 2.61 | 2.51 | 2.51 | 1.76 | 1.6 |
Net Income | 7.61 | 7.58 | 8.1 | 8.37 | 7.67 |
Net Income to Common | 7.61 | 7.58 | 8.1 | 8.37 | 7.67 |
Net Income Growth | 0.40% | -6.33% | -3.29% | 9.10% | 14.01% |
Shares Outstanding (Basic) | 5 | 5 | 5 | 5 | 5 |
Shares Outstanding (Diluted) | 5 | 5 | 5 | 5 | 5 |
Shares Change | 0.17% | -0.08% | 0.14% | 0.56% | -0.03% |
EPS (Basic) | 1.46 | 1.45 | 1.55 | 1.61 | 1.47 |
EPS (Diluted) | 1.44 | 1.43 | 1.53 | 1.58 | 1.46 |
EPS Growth | 0.23% | -6.26% | -3.42% | 8.48% | 14.04% |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | 7.88 | 7.01 | 8.33 | 7.79 | 7.55 |
Free Cash Flow Per Share | 1.49 | 1.32 | 1.57 | 1.47 | 1.44 |
Dividend Per Share | 1.500 | 1.500 | 1.550 | 1.520 | 1.260 |
Dividend Growth | 0% | -3.23% | 1.97% | 20.64% | 20.00% |
Gross Margin | 91.45% | 90.86% | 93.20% | 93.54% | 93.94% |
Operating Margin | 77.28% | 76.80% | 78.10% | 78.57% | 78.34% |
Profit Margin | 58.70% | 57.83% | 59.51% | 65.33% | 65.48% |
Free Cash Flow Margin | 60.77% | 53.47% | 61.21% | 60.80% | 64.38% |
EBITDA | 10.08 | 10.17 | 10.74 | 10.2 | 9.32 |
EBITDA Margin | 77.71% | 77.51% | 78.93% | 79.58% | 79.56% |
D&A For EBITDA | 0.06 | 0.09 | 0.11 | 0.13 | 0.14 |
EBIT | 10.03 | 10.07 | 10.63 | 10.07 | 9.18 |
EBIT Margin | 77.28% | 76.80% | 78.10% | 78.57% | 78.34% |
Effective Tax Rate | 25.55% | 24.88% | 23.64% | 17.39% | 17.29% |